Design Therapeutics (DSGN) Net Income towards Common Stockholders: 2020
Historic Net Income towards Common Stockholders for Design Therapeutics (DSGN) over the last 1 years, with Dec 2020 value amounting to -$8.3 million.
- Design Therapeutics' Net Income towards Common Stockholders was N/A to -$3.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$8.3 million, marking a year-over-year change of. This contributed to the annual value of -$8.3 million for FY2020, which is N/A change from last year.
- According to the latest figures from FY2020, Design Therapeutics' Net Income towards Common Stockholders is -$8.3 million.
- In the past 5 years, Design Therapeutics' Net Income towards Common Stockholders registered a high of -$8.3 million during FY2020, and its lowest value of -$8.3 million during FY2020.
- In the last 1 years, Design Therapeutics' Net Income towards Common Stockholders had a median value of -$8.3 million in 2020 and averaged -$8.3 million.